InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Tucker John H, 董事长兼首席执行官. Officer active across 1 company, notably scPharmaceuticals Inc.. Cumulatively, 8 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €35k. History available since 3 December 2021. The latest transaction was disclosed on 11 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Tucker John H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
122,345 股Common StockSEC:0001193125-25-233532:0
200,000 股0Common StockSEC:0000950170-25-018923:0
13,360 股@ US$3.55878.8% 占其流量Common StockSEC:0000950170-25-002872:0
113,560 股0Common StockSEC:0000950170-24-006214:0
4,942 股@ US$6.395.5% 占其流量Common StockSEC:0000950170-24-000976:0
66,665 股@ US$6.1472.3% 占其流量Common StockSEC:0000899243-23-002427:0
42,250 股Common StockSEC:0000899243-22-033404:0
10,000 股@ US$3.95537.2% 占其流量Common StockSEC:0000899243-21-046979:0
标准退出：2022年3月3日 (T+90)
8 条申报中的 8 条
About Tucker John H
Tucker John H is President-Directeur Général and President and CEO at scPharmaceuticals Inc. The declarant has 8 filings in total, and across the 8 sampled filings the recorded activity runs from 2021-12-06 to 2025-10-07, with buy volume of EUR 34983 and no sell volume reported. The most frequent transaction nature shown is Attribution.
